Changeflow GovPing Healthcare Chronic rhinitis electrosurgical treatment, Oly...
Routine Notice Added Final

Chronic rhinitis electrosurgical treatment, Olympus patent

Favicon for changeflow.com ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B)
Published
Detected
Email

Summary

The USPTO granted patent US12594116B2 to Olympus Winter & Ibe GmbH on April 7, 2026. The patent covers a method for treating chronic rhinitis using a handheld electrosurgical applicator for treatment of hypertrophic nasal conchae and/or submucosal ablation of the posterior nasal nerve to reduce cardinal symptoms. The patent was filed in July 2022 and includes 2 claims.

What changed

The USPTO issued patent grant US12594116B2 to Olympus Winter & Ibe GmbH for a method of treating chronic rhinitis via electrosurgical intervention. The invention provides a treatment using a handheld surgical instrument, specifically an electrosurgical applicator, for reducing hypertrophic nasal conchae and/or ablating the posterior nasal nerve submucosally to alleviate rhinitis symptoms with fewer adverse effects than existing methods.

Medical device manufacturers developing electrosurgical instruments for ENT applications should monitor this patent landscape. Competitors seeking to manufacture similar handheld electrosurgical applicators for chronic rhinitis treatment may need to evaluate potential licensing requirements or design-around strategies to avoid infringement on the granted claims.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 8, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Method for treating chronic rhinitis

Grant US12594116B2 Kind: B2 Apr 07, 2026

Assignee

OLYMPUS WINTER & IBE GMBH

Inventors

Claudia Alexandra Bohnsack

Abstract

A method for treating patients who suffer from chronic rhinitis that is efficient and causes fewer adverse effects than known methods. This is achieved by using a handheld surgical instrument, more particularly an electrosurgical applicator, for treatment of hypertrophic nasal conchae and/or for submucosal treatment of the posterior nasal nerve (PNN) in order to reduce at least one cardinal symptom of chronic rhinitis.

CPC Classifications

A61B 18/1485 A61B 2018/00327 A61B 2018/00434 A61B 2018/00875 A61B 2018/1253 A61B 2018/126 A61B 2018/1465 A61B 2018/1467 A61B 2018/147

Filing Date

2022-07-25

Application No.

17872770

Claims

2

View original document →

Get daily alerts for ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12594116B2

Who this affects

Applies to
Medical device makers Manufacturers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical device manufacturing Electrosurgical device manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.